Background and purpose Immune checkpoint inhibitors (ICIs) targeting programmed death
receptor 1 (PD‐1), cytotoxic T‐lymphocyte‐associated‐4 (CTLA‐4) and programmed cell …

Autoimmune dementia is a potentially treatable condition and should not be missed in
clinical practice given the potential for reversibility with immunotherapy. The diagnosis of …

Introduction The association of myelin oligodendrocyte glycoprotein (MOG) antibody
associated disease (MOGAD) and tumors has seldom been reported. We aim to investigate …

Background and Objectives To define the clinical and immunologic profile of patients with
paraneoplastic neurologic syndromes (PNSs) associated with Merkel cell carcinoma (MCC) …

Interest of rare autoantibodies in autoimmune encephalitis a... : Current Opinion in Neurology
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological …

Objective Describe the demographic data and clinical phenotype of cranial palsy induced by
immune checkpoint inhibitors (CNP-ICI). Methods A systematic literature review of the …

 Abstract Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, and the
association with immune-related adverse events (irAEs) is well-established. However …

Background Immune checkpoint inhibitors (ICI) may trigger autoimmune neurological
conditions, including movement disorders (MD). Objectives The aim of this study was to …

Neuroendocrine neoplasms (NENs) are a heterogeneous group of tumors arising from the
transformation of neuroendocrine cells in several organs, most notably the gastro-entero …

Discussion Neurofilaments are essential components of the neuronal cytoplasm,
characterized by their intermediate filament structure, including α internexin (αIN) …